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 Among the antitumor drugs, bacterial enzyme L-asparaginase has been employed as the most effective 
chemotherapeutic agent in pediatric oncotherapy especially for acute lymphoblastic leukemia. In previous 
study, the L-asparaginase from Erwinia chrysanthermy was expressed in Escherichia coli BL21(DE3). The 
recombinant L-asparaginase was produced from recombinant E.coli BL21(DE3) under different cultivation 
conditions (inducer concentration, inoculum concentration and KH2PO4 concentration). The optimized 
conditions by response surface methodology using face centered central composite design. The analysis of 
variance coupled with larger value of R2 (0.9) showed that the quadratic model used for the prediction was 
highly significant (p < 0.05). Under the optimized conditions, the model produced L-asparaginase activity of 
123.74 U/ml at 1.03 mM IPTG, 3% (v/v) inoculum and 0.5% (w/v) KH2PO4. Recombinant protein was 
purified by two step using gel filtration and DEAE chromatography. The purified L-asparaginase had a 
molecular mass of 37 kDa with specific activity of 462 U/mg and identified by MALDI-TOF mass 
spectrometry. Results of MALDI-TOF analysis confirmed that recombinant protein was L-asparaginase II. 
Recombinant L-asparaginase has antiproliferative activity with K562 cell line. In conclusion, this study has 
innovatively developed cultivation conditions for better production of recombinant L-asparaginase in shake 
flask culture. 
Keywords: Escherichia coli BL21(DE3), K562, L-asparaginase, MALDI-TOF, response surface 
INTRODUCTION 
 L-asparaginase (L-asparagine aminohydrolase, 
EC 3.5.1.1) which catalyses the hydrolysis of the 
amide group of asparagine to yield aspartate and 
ammonia is an important enzyme as therapeutic 
agents used in combination therapy with other drugs 
in the treatment of acute lymphoblastic leukemia in 
children, Hodgkin disease, acute myelocytic 
leukemia, acute myelomonocytic leukemia, chronic 
lymphocytic leukemia, lymphosarcoma treatment, 
reticulosarcoma, and melanosarcoma (Stecher et al. 
1999; Verma et al. 2007). The drug depletes the 
blood of asparagine, nonessential amino acid on 
which many cells depend for normal metabolic 
processes. Whereas normal cells compensate by 
synthesizing L-asparagine from aspartic acid and 
glutamine via the enzyme, asparagine synthetase, 
selected malignant lymphoid cells have low levels of 
the synthetic enzyme and depend on intracellular 
pools of L-asparagine for protein synthesis and cell 
functioning (Broome 1981; El-Bessoumy et al. 
2004)This deprives the leukemic cell of circulating 
asparagine, which leads to cell death. The L-
asparaginases of Erwinia chrysanthemi (Erw. 
chrysanthemi) and Escherichia coli (E. coli) have 
been employed for many years as effective drugs in 
the treatment of acute lymphoblastic leukemia and 
leukemia lymphosarcoma (Graham 2003). L-
asparaginase has an antioxidant property (Maysa et 
al. 2010). It is also used in food industry as a food 
processing aid; it can effectively reduce the level of 
acrylamide up to 90% in a range of starchy fried 
foods without changing the taste and appearance of 
the end product (Hendriksen et al. 2009) 
 Production of L-asparaginase is greatly 
influenced by fermentation medium composition and 
culture conditions such as temperature, pH, 
inoculum size, agitation rate, and incubation time 
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(Hymavathi et al. 2009). Production of recombinant 
L-asparaginase from E. coli, optimization of culture 
medium composition and expression condition are 
important strategies to enhance the yield of 
biological active L-asparaginase. Response surface 
methodology (RSM) have been used for many 
decades by several researchers in biotechnology for 
an optimization strategy (El-Naggar et al. 2015; Erva 
et al. 2017; Kumara et al. 2013) and can be adopted 
on several steps, the first step is to screen the 
important parameters and the second step is to 
optimize those parameters (Nawani & Kapadnis 
2004). These have several advantages that included 
less experiment numbers, suitability for multiple 
factor experiments, search for relativity between 
factors, and finding of the most suitable conditions 
and forecast response (Chang et al. 2006). Response 
surface methodology (RSM) is an efficient strategic 
experimental tool by which the optimal conditions of 
a multivariable system can be determined. In the 
present study, strain recombinant E. coli BL21(DE3) 
harboring gene L-asparaginase was optimized 
expression condition using design of experiments 
and response surface methodology to enhance the 
production of the active form of recombinant L-
asparaginase. The biological activity of recombinant 
L-asparaginase was also tested on human blood 
cancer cell line. 
MATERIALS AND METHODS 
Bacterial Strains  
 Recombinant E.coli BL21(DE3) harboring gene 
L-asparaginase (E-ASPG) was obtained from 
Department of Enzyme Biotechnology, Institute of 
Biotechnology, Vietnam Academy of Science and 
Technology, Vietnam. 
 Strain E-ASPG was grown in Lysogeny broth 
(LB) (pH 7.0) which comprised peptone (10 g/L), 
yeast extract (5 g/L), and NaCl (10 g/L)l. 
Chemicals 
 L-asparagine, Nessler’s reagent were from 
Sigma (Louis, USA). IPTG, trichloroacetic acid, 
bactotryptone and yeast extract were from Bio Basic 
Inc (New York, USA)… All other reagents were of 
analytical grade unless otherwise stated.  
Culture condition 
 Strain E-ASPG was grown in Lysogeny broth. 
Inoculum of overnight cultures (1%) grown in LB 
medium was made in 25 mL LB medium in 100 mL 
Erlenmeyer conical flasks and grown to an optical 
density at 600 nm (OD600 nm) 0.4 - 0.6 at 37ºC with 
shaking at 220 rpm. IPTG was then added to 1 mM 
final concentration, the culture was continuously 
incubated at 28°C with agitation of 220 rpm for 6 h 
of induction. Cells were harvested by centrifugation 
8000 rpm/5 min. 
Enzyme assay 
 Activity analysis of L-asparaginase II was 
performed according to Chung et al (Chung et al. 
2010) using Nessler’s reagent to measure the 
released ammonia after L-asparagine hydrolysis. The 
enzyme activity of recombinant protein was 
determined using an ammonium sulphate calibration 
curve. One unit of enzyme activity was defined as 
the amount of enzyme required to release 1 µM of 
ammonia per minute. 
Response surface methodology  
 The parameters namely induction concentration, 
inoculum concentration and KH2PO4 were 
optimized. These values were used in the RSM 
design and are as shown in Table 1.  
 
Table1. Experimental range and level of the process variables for L-asparaginase production. 
 
Component Unit Variables Range Level 
  -1,316 (-α)  -1 0 +1 +1,316 (+α) 
IPTG concentration mM A 0,04 -1,36 0,04 0,2 0,7 1,2 1,36 
Inoculum 
concentration 
% (v/v) B 0,68-3,32 0,68 1 2 3 3,32 
KH2PO4 
concentration 
% (w/v) C 0,26-2,24 0,26 0,5 1,25 2 2,24 
 
 For each run triplicate study was carried out. 
The 20 set of batch experiments designed by 
software are as given in Table 2. All the experiments 
were carried out in triplicates and the average of L-
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asparaginase activity (U/ml) was considered as the 
response (Y). The following second-order 
polynomial equation explains the relationship 
between dependent and independent variables: 
 Y = b0 + b1A + b2B + b3C + b11A2 + b22B2 + 
b33C2 + b12AB + b23BC + b13AC where Y is the 
dependent variable (L-asparaginase production); A, 
B and C are independent variables (inducer 
concentration, inoculum concentration and KH2PO4 
concentration, respectively); b0 is an intercept term; 
b1, b2 and b3 are linear coefficients; b12, b13 and 
b23 are the interaction coefficients; and b11, b22 and 
b33 are the quadratic coefficients. The evaluation of 
the analysis of variance (ANOVA) was determined 
by conducting the statistical analysis of the model. In 
order to depict the relationship between the 
responses and the experimental levels of each of the 
variables under study, the fitted polynomial equation 
was expressed in the form of contour and response 
surface plots. 
Table 2. RSM design for L-asparaginase production with experimental  and predicted L-asparaginase activity     
Trails A B C L-asparaginase activity (U/mL) 
    Experimental Predicted 
1 1 -1 -1 105.248 ± 0.912 107.600 
2 -1 -1 1 51.488 ± 0.101 47.336 
3 -1 -1 -1 108.76 ± 0.405 102.722 
4 1.316 0 0 98.581 ± 0.101 88.559 
5 1 1 1 92.883 ± 0.456 91.392 
6 -1 1 -1 106.072 ± 0.963 95.523 
7 0 0 0 100.983 ± 0.558 95.605 
8 0 0 0 94.782 ± 0.811 95.605 
9 1 1 -1 114.064 ± 1.419 122.622 
10 1 -1 1 49.194 ± 0.811 52.214 
11 -1 1 1 62.24 ± 1.318 64.293 
12 0 0 -1.316 120.659 ± 0.405 124.104 
13 0 0 0 97.327 ± 2.788 95.605 
14 0 0 0 98.223 ± 0.101 95.605 
15 0 1.316 0 102.882 ±0.608 106.127 
16 0 0 1.316 67.544 ± 0.203 67.107 
17 0 -1.316 0 79.264 ± 0.152 85.084 
18 -1.316 0 0 53.889 ± 0.152 67.517 
19 0 0 0 101.305 ± 0.101 95.605 
20 0 0 0 90.446 ± 0.152 95.605 
 
Protein purification 
 The supernatant cell free extract containing the 
crude L-asparaginase was loaded into sephacryl S-
200 column (2.6 ´ 6 cm) equilibrated with 50 mM 
potassium phosphate (pH 8) and eluted with the 
same buffer at the flow rate of 0.5 ml per minute. 
Fractions showing L-asparaginase activity were 
pooled and concentrated with bench top protein 
concentrator at 4°C. The homogeneity of the protein 
was checked by SDS -PAGE. The concentrated 
enzyme solution was added on the top of 
diethylaminoethyl sepharose ion exchange column 
(DEAE - sepharose) (2.6 ´ 6 cm) equilibrated with 
50 mM Tris HCL (pH 8.6). The column was washed 
with 2 volumes of starting buffer and the protein was 
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eluted with linear gradient of NaCl (0 - 1 M) 
prepared in 50 mM Tris HCL (pH 8.6) at the rate of 
30 ml per hour. The eluate was collected with 1.5 ml 
per fractions. The fractions showing L-asparaginase 
activity were stored at 4°C.  
Molecular weight determination and quantitative 
protein determination 
 The molecular weight (MW) of the purified 
protein was determined using sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE).according to the method of Laemmli 
(Laemmli 1970).  
 Protein concentrations were estimated using the 
Bradford method, with BSA as the standard 
(Bradford 1976). 
Protein identification 
 The purified protein was identified by MALDI-
TOF mass spectrometry. The predicted protein was 
trypsin-digested and peptides were extracted 
according to standard techniques (Bringans et al. 
2008). Peptides were analyzed by MALDI-
TOF/TOF mass spectrometer using a 5800 
Proteomics Analyzer (AB Sciex)(Applied 
Biosystems, USA). Spectra were analyzed to identify 
the protein of interest using Mascot sequence 
matching software (Matrix Science (Matrix Science 
Ltd, UK) with the MSPnr100 Database. Peptide 
fragments showing ion scores of >59 were identified 
as unique or highly similar (P < 0.01). 
Antiproliferative activity of L-asparaginase 
 The human leukemia cell line K562 (chronic 
myelogenous leukemia) were used in this study. The 
antiproliferative activity of recombinant L-
asparaginase was evaluated by the MTT reduction 
assay (Shanmugaprakash et al. 2015) 
RESULTS AND DISCUSSION 
Optimization of recombinant L-asparaginase 
using response surface methodology 
 The effect of medium components and condition 
expression (KH2PO4 concentration, inducer 
concentration, and inoculum concentration) on the L-
asparaginase production was investigated. Table 2 
shows the CCD design and the levels of each 
variable, L-asparaginase activity as the responses. 
The wide range of L-asparaginase activity from 49.2 
to 120.7 U/ml was observed under these investigated 
expression condition. Correlation of L-asparaginase 
activity and the investigated variables was 
determined using the Design Expert sofware and was 
represented by the following equation: 
Y  = 95,61 +7,99*A +7,9 *B -21,65*C + 5,56 
*A*B + 6,04*B*C - 10,14*A2 
 Where the response (Y) is the L-asparaginase 
activity, while A, B and C are the inducer 
concentration, inoculum concentration and KH2PO4 
concentration, respectively. 
 The analysis of variance (ANOVA) tested using 
Fisher’s statistical analysis, was used to verify the 
adequacy of the model. The closer R2 is to the 1, the 
stronger the model is and the better it predicts the 
response (Kaushik et al. 2006). In this case, the 
value of the determination coincident (R2 = 0.921) 
indicates that 92.1% of the variability in the response 
was attributed to the given independent variables and 
only 6.9% of the total variations are not explained by 
the independent variables. In addition, the value of 
the adjusted determination coefficient (Adj R2 = 
0.884) is also very high which indicates a high 
significance of the model. In this model, a lower 
value of 8.17 for the coefficient of variation (CV), 
suggested a good precision and reliability of the 
experiment. As lack of fit is not significant, it clearly 
implies that the obtained experimental responses 
adequately fit with the model. 
 In order to understand the interactions of 
induction expression and to find the optimum 
conditions required for maximum L-asparagianse 
production, the 3-D response surface curves were 
plotted. Figure 1 shows the interaction between 
inoculum concentration and inducer concentration by 
keeping K2HPO4 concentration at optimum value. It 
showed that increase of IPTG concentration and 
inoculum concentration result in higher L-
asparaginase activity; the highest value of L-
asparaginase activity was obtained with high level of 
IPTG and inoculum concentration. It can be seen that 
maximum L-asparaginase production was attained at 
inducer concentration of 1.03 mM and  inoculum 
concentration of 3% (v/v). .The analysis of the plots 
also demonstrated that the highest asparaginase 
activity was achieved when the concentrations of 
K2HPO4 were 0.5% (w/v). Further increase in 
K2HPO4 concentration decreases the activity.  
 Theoretical maximum enzyme activity (123.74 
U/ml) was obtained at the optimal values of IPTG 
concentration at 1.03 mM, inoculum concentration at 
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3% (v/v) and KH2PO4 at 0.5% (w/v). Validation of 
model was carried out with the optimum values 
predicted by the software. Results showed that 
experimental value of enzyme activity (120 U/ml) 
was very closer to the predicted response and the 
predicted model fitted well (Figure 3). 
Design-Expert® Software
ASPG
Design points above predicted value
Design points below predicted value
120.659
49.194
X1 = A: IPTG
X2 = B: Inoculum
Actual Factor






















  A: IPTG    B: Inoculum  
 
Figure 2. Response surface plot of asparaginase production by recombinant E. coli showing the effect of inoculum concentration and IPTG concentration 
 
 
                                                                                               
 
Figure 3A . SDS–PAGE analysis of L-
asparaginase expression at otimum condition. 
Lane 1:  EASPG with IPTG induction, Lane 2: 
EASPG without induction, M: protein marker 
Figure 3B. SDS-PAGE of the overexpressed and purified of  
rASPG in E. coli BL21 (DE3). (Lane M: molecular mass of 
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 Theoretical maximum enzyme activity (123.74 
U/ml) was obtained at the optimal values of IPTG 
concentration at 1.03 mM, inoculum concentration at 
3% (v/v) and KH2PO4 at 0.5% (w/v). Validation of 
model was carried out with the optimum values 
predicted by the software. Results showed that 
experimental value of enzyme activity (120 U/ml) 
was very closer to the predicted response and the 
predicted model fitted well (Figure 3A). 
 According to the results of our study the most 
important factors affecting protein expression is 
inducer concentration low inducer concentration may 
result in an inefficient induction and consequently, 
low recombinant protein yields. On the other hand, 
inducers added in excess can result in toxic effects 
including reduced cell growth or resulting in high 
protein expression, but it was inclusion bodies which 
were inactive forms of the recombinant proteins. 
Inoculum concentration also affects the recombinant 
L-asparaginase yield, higher levels of inoculum 
increases recombinant L-asparaginase yield but 
inoculum level depends on the inducer 
concentration. Another aspect of expression of 
recombinant L-asparaginase is KH2PO4 
concentration, higher levels of KH2PO4 decreases 
recombinant L-asparaginase expression and its level 
depends on the inoculum concentration. In study of 
Bahreini et al (2014) high cell densities can be
obtained associated with improving the productivity 
of recombinant L-asparaginase per cell but optimal 
IPTG concentration was very low (Bahreini et al. 
2014).  
Identification recombinant enzyme 
 The recombinant EASPG strain was expressed at 
optimum condition to harvest recombinant enzymes. 
The rASPG was purified from the cell lysis of 
EASPG by filter chromatography sephacryl S-200 
and DEAE sepharose showed only one protein band 
about 37 kDa on SDS-PAGE (Fig.3B). 
 The specific activity of recombinant L-
asparaginase after two step purification obtained by 
462 U/mg with a yield of 44% and purification factor 
of 4.55 (Table 4). The specific activity was very 
different: The activity of purified recombinant L-
asparaginase II from E. coli K-12 express in E. coli 
BLR(DE3) was 190 U/mg, recombinant L-
asparaginase II from Erw. chrysanthemi 3937 
express in E. coli BL21(DE3)pLysS was 118.7 U/mg  
(Kotzia & Labrou 2007), L-asparaginase II from B. 
subtilis express in E. coli JM109 (DE3) was 45.5 
U/mg  L-asparaginase from Rhizomucor miehei 
express in E. coli was 1.985 U/mg  and activity of 
purified L-asparaginase from B. licheniformis was 
697.09 U/mg. 
Table 4. Purification procedure of rASPG from the cell lysate of EASPG. 
Purification 
steps 




Yield (%) Purification 
factor 
Cell lysis 360 2 45 100 1 
Sephacryl S-200 318 0.52 101.6 88.5 2.26 
DEAE-Sepharose 143 0.1 462.5 44.9 4.55 
  
 
Figure 5 . Alignment of three neutral identified peptides (3 peptides) with L- asparaginase from (WP-039108651). 
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 Identification of recombinant ASPG the single 
protein on SDS -PAGE (Fig.4) was cut out from the 
gel and used for MALDI -TOF analysis. There 
peptide fragments of the purified enzyme identified 
by MALDI -TOF mass spectrometry agreed with 
those of the L-asparaginase found in GenBank WP-
039108651 GVMVVLNDR (position 171-179), 
GRGVMVVLNDR (position 169–179), 
TNATSLDTFR (position 189-198) (Figure 6). 
Whereas the peptide fragments showing ion scores 
above 44 were identified uniquely or highly similarly 
to p < 0.05. These peptides of the recombinant 
enzyme expressed by EASPG was matched to L- 
asparaginase resulting in a sequence coverage of 7% 
(relative RMS error = 90 ppm), mascot PMF score 
was 147, mass was 36777 Da. 
Antiproliferative activity of recombiant L-
asparaginase 
 The antiproliferative effects of L-asparaginase 
were evaluated on the human leukemia cell line 
K562 by using MTT cell viability assay. It was 
observed from Figure 6 that incubation of K562 with 
L-asparaginases resulted in decrease in the number 
of viable (metabolically active) cells as compared 
with control.  
 Recombinant L-asparaginase showed positive 
activity against leukemia cell line K562. The number 
of surviving cells decreases with increasing rASPG 
concentration. Recombinant L-asparaginase at 




                                    A    B 
















Figure 7. Recombiant L-sparaginase induces growth inhibition in K562 CML cells 
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 In another study conducted by Guo et al., it was 
showed that the antitumor effects of L-asparaginase 
were observed in vitro with tumor cells K562, 
L1210, and P815 (P<0.01). As the concentration of 
recombinant L-asparaginases increased from 2.5-40 
mg/L, the inhibitory rate with K562 increased from 
20-50% (Guo et al. 2002). Song et al also showed 
that treatment of K562 and KU812 cells with 
different concentrations of asparaginase (0.02, 0.1, 
and 0.5 IU/mL) for 48 h, K562 cells increased the 
percentage of apoptotic cells (Song et al. 2015). 
CONCLUSION 
 In conclusion, we were successful to optimize 
recombinant L-asparaginase expression and 
purification. The levels of the significant variables 
were optimized using response surface methodology 
with the following conditions; IPTG concentration 1 
mM, inoculum concentration 3% (v/v) and KH2PO4 
0.5% (w/v). Recombinant enzyme was purified and 
confirmed to be exactly L-asparaginase by 
MALDI-TOF. L-asparaginase has antiproliferative 
activity with human leukemia cell K562.  
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TỐI ƯU HÓA KHẢ NĂNG SINH TỔNG HỢP L-ASPARAGINASE TÁI TỔ HỢP TỪ 
CHỦNG ESCHERICHIA COLI SỬ DỤNG PHƯƠNG PHÁP ĐÁP ỨNG BỀ MẶT  
 
Nguyễn Thị Hiền Trang, Lê Thanh Hoàng, Đỗ Thị Tuyên 
Viện Công nghệ sinh học, Viện Hàn lâm khoa học và Công nghệ Việt Nam 
TÓM TẮT 
 Enzyme L_asparaginase từ vi khuẩn là một trong những thuốc sử dụng điều trị ung thư máu ở người, hiệu 
quả nhất trong điều trị ung thư bạch cầu cấp tính. Trong những nghiên cứu trước, L-asparaginase từ Erwinia 
chrysanthermy đã được chúng tôi biểu hiện thành công trong Escherichia coli BL21(DE3). Trong nghiên cứu 
này chúng tôi sử dụng phương pháp đáp ứng bề mặt để tối ưu điều kiện nuôi cấy biểu hiện cho sinh tổng hợp 
enzyme tái tổ hợp đạt hoạt tính cao. Các thông số lựa chọn để tối ưu bao gồm: nồng độ chất cảm ứng IPTG, tỉ 
lệ giống và tỉ lệ KH2PO4. Bằng phương pháp quy hoạch thực nghiệm đã xây dựng được phương trình hồi quy 
mô tả mối quan hệ giữa hoạt tính enzyme và các biến tối ưu với hệ số hồi quy R2 là 0.9, mức ý nghĩa cao với p 
< 0,05. Mô hình đã dự đoán hoạt tính L-asparaginase tái tổ hợp tối đa đạt được là 123,74 U/ml ở các giá trị yếu 
tố 1,03 mM IPTG, 3 % (v/v) tỉ lệ giống tiếp và 0,5 % (w/v) KH2PO4. Enzyme tái tổ hợp sau khi được tinh sạch 
đã được nhận dạng chính xác bằng phương pháp MALDI_TOF. L-asparaginase tinh sạch đạt hoạt tính riêng 
462 U/mg và có hoạt tính ức chế sinh trưởng với dòng tế bào ung thư tủy mãn của người K562.  
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